Cardio Diagnostics Holdings Inc. - רווח נקי למניה בארבעת הרבעונים האחרונים CDIO
The GURU.Markets terminal provides a chart of the annual net income per share TTM trend, where the value 35.80 characterizes this level. The growth of Cardio Diagnostics (CDIO) relies on the demand for epigenetic tests and the expansion of insurance coverage. A scalable cloud IT infrastructure ensures uninterrupted data analysis, while unique AI diagnostic technologies enable the company to exercise pricing power through premium service rates.
CDIO (Cardio Diagnostics Holdings, Inc.): פילוחים אנליטיים ודוחות לפי אינדיקטורים
For Cardio Diagnostics (CDIO), the YoY EPS volatility over the last 12 months reflects the impact of geopolitical fragmentation on the export of diagnostic systems. This metric measures the annual growth rate of net income per share over a rolling period. The calculation is based on a comparison of current aggregate earnings with the equivalent window from the previous year. This trend captures the sensitivity of profitability to logistic disruptions in reagent supplies. The growth of this metric confirms the effectiveness of business scaling amidst market isolation.
